Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial
The Lancet. Respiratory medicine(2023)
摘要
Alexion, AstraZeneca Rare Disease.
更多查看译文
关键词
intravenous ravulizumab,patients,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要